No—This Patient's Diagnosis is Not Limited to Anxiety Alone
This patient meets criteria for multiple comorbid psychiatric diagnoses, most prominently major depressive disorder with a history of serious suicide attempt, panic disorder, and generalized anxiety disorder, along with insomnia disorder. The clinical presentation demands recognition of this diagnostic complexity rather than reduction to a single anxiety diagnosis.
Diagnostic Framework
Primary Diagnoses Present
Major Depressive Disorder is clearly evident and takes diagnostic priority. The patient demonstrates:
- Persistent sadness and pervasive fear interfering with daily functioning
- Significant functional impairment requiring resignation from a 16-year career
- Social withdrawal and isolation (spending prolonged periods in room)
- A serious suicide attempt with a firearm approximately two years ago
- Insomnia resulting in only a few hours of sleep over several days
- Impaired energy and cognitive functioning
Panic Disorder is well-documented with:
- Recurrent panic attacks (previously 5-6 per day)
- Classic panic symptoms: hyperventilation, tachycardia, diaphoresis, flushing sensation
- Evolution to more internalized episodes with persistent fear and avoidance
- Anticipatory anxiety and urgency sensations
Generalized Anxiety Disorder features include:
- Longstanding pervasive anxiety and worry
- Fear of disappointing others
- Avoidance behaviors triggered by anxiety
- Chronic nature spanning years with progressive worsening
Critical Comorbidity Pattern
The evidence strongly supports that 50-60% of individuals with diagnosed depressive disorder have comorbid anxiety disorder, with generalized anxiety being most prevalent 1. This patient exemplifies this pattern perfectly. The guidelines explicitly state that when comorbid anxiety and depression exist, the usual practice is to treat the depression first 1.
Why This Matters for Morbidity and Mortality
Suicide Risk Remains the Priority Concern
The patient's history of a firearm suicide attempt two years ago represents the highest mortality risk factor in this presentation. While she currently denies suicidal ideation, the combination of:
- Major depression
- Multiple anxiety disorders
- Chronic pain conditions
- History of serious suicide attempt
...creates an ongoing elevated risk profile that cannot be dismissed by focusing solely on anxiety symptoms 1.
Functional Impairment Severity
The patient's symptoms progressed to:
- Complete occupational disability (career resignation)
- Severe social isolation
- Inability to engage in daily activities
- Living separately from ex-husband while still in same home
This degree of functional impairment far exceeds what would be expected from anxiety alone and reflects the severe depressive component with major life area impairment 1.
Differential Diagnostic Considerations
Medical Contributors Requiring Evaluation
Iron deficiency anemia is documented in this patient and represents a critical medical factor. Recent evidence demonstrates that iron deficiency is significantly associated with anxiety (OR=1.88, p<0.001) and depression (OR=2.06, p<0.001) 2. Additionally, iron deficiency correlates with:
- Chronic pain conditions (which this patient has extensively)
- Insomnia and sleep disturbances
- Cognitive dysfunction
- Fatigue
The patient's chronic musculoskeletal pain from multiple orthopedic injuries and surgeries may be both contributing to and exacerbated by untreated or undertreated iron deficiency 2, 3.
Chronic pain itself (bilateral hip replacements, back surgery, neck fracture repair, ongoing back and hip pain) represents both:
- A potential contributor to depressive and anxiety symptoms
- A condition that may be worsened by iron deficiency
- A factor requiring integrated pain management alongside psychiatric treatment 1
Sleep Architecture Disruption
The severe insomnia described (only a few hours of sleep over several days) is bidirectionally related to both anxiety and depression. In GAD specifically, over 80% of patients suffer from insomnia with prolonged sleep latency and non-restorative sleep 4. Panic disorder involves nocturnal panic attacks creating anticipatory anxiety around sleep itself 4. Treating insomnia can be of great benefit to patients with GAD 5.
Treatment Implications of Accurate Diagnosis
Stepped Care Model Requirements
The guidelines mandate using a stepped care model tailored to 1:
- Current symptomatology level and DSM-5 diagnosis presence
- Level of functional impairment in major life areas (severe in this case)
- Presence of risk factors (suicide attempt history)
- History and response to previous treatments
- Patient preference
- Symptom persistence after initial treatment
Pharmacologic Approach
Depression should be treated first when comorbid with anxiety disorders 1. The patient is currently on:
- Lexapro (SSRI—appropriate for both depression and anxiety)
- Xanax (benzodiazepine—concerning for long-term use)
- Lunesta (for insomnia—showing benefit)
Critical medication concerns:
- Benzodiazepines (Xanax) have decreased long-term effectiveness and minimal treatment of psychic symptoms 5
- The patient reports running low on several medications—medication adherence and access must be immediately addressed
- Gabapentin for pain may provide some anxiolytic benefit but is not primary psychiatric treatment
Non-Pharmacologic Interventions
The patient benefited significantly from residential treatment structure, which provided:
- Medication adherence support
- Psychoeducation
- Coping skills development
- Structured environment
Continued psychotherapy is essential, specifically:
- Cognitive-behavioral therapy for both depression and anxiety 1
- Trauma-focused therapy given childhood maternal abandonment
- Relapse prevention given suicide attempt history
Medical Optimization
Iron deficiency anemia must be actively treated given its documented associations with depression, anxiety, chronic pain, and cognitive symptoms 2, 3, 6. The patient receives B12 and NAD+ injections but iron repletion status should be verified and optimized.
Follow-Up Requirements
Given the severity and complexity, biweekly to monthly assessment is required until symptom remission 1, monitoring:
- Suicidal ideation (despite current denial, history mandates ongoing assessment)
- Treatment adherence (especially given medication supply issues)
- Functional improvement in major life areas
- Medication adverse effects and satisfaction
- Psychotherapy engagement and benefit
After 8 weeks of treatment, if symptom reduction is poor despite good compliance, alter the treatment course (add interventions, change medications, refer to specialized care) 1.
Common Pitfalls to Avoid
- Minimizing the depressive component because anxiety symptoms are prominent—depression with suicide attempt history takes precedence
- Overlooking medical contributors (iron deficiency, chronic pain) that may perpetuate psychiatric symptoms
- Failing to address medication access issues—patient reports running low on medications
- Underestimating ongoing suicide risk based on current denial when history is severe
- Treating anxiety alone when guidelines explicitly recommend treating depression first in comorbid presentations 1
- Long-term benzodiazepine continuation without reassessment of risks versus benefits 5
This patient requires integrated psychiatric care addressing major depressive disorder, panic disorder, generalized anxiety disorder, insomnia, and medical optimization of iron deficiency anemia and chronic pain—not treatment of anxiety alone.